| |
1st Quarter
2005 |
1st Quarter
2006 |
| EUR million |
|
|
| Changes in fair values of hedging instruments
and available-for-sale securities,
recognized in stockholders’ equity |
25 |
9 |
Actuarial gains/losses on defined benefit
obligations for pensions
and other post-employment benefits |
– |
805 |
| Exchange differences on translation of operations
outside the euro zone |
442 |
(144) |
| Deferred taxes on valuation adjustments, recognized
directly in stockholders’ equity |
(10) |
(315) |
| Valuation adjustments recognized
directly in stockholders’ equity |
457 |
355 |
| Income after taxes |
645 |
597 |
| Total income and expense recognized
in the financial statements |
1,102 |
952 |
| of which attributable to minority
interest |
1 |
(5) |
| of which attributable to Bayer
AG stockholders |
1,101 |
957 |